Importance of early life factors found in new lung cancer research

Published Date: 08 Mar 2023

A groundbreaking study by the University of Bristol and the University of Essex has revealed new insights into the importance of early childhood for lung health.

Read Full News

Latest News

People abused by intimate partners have worse asthma—researchers are still investigating this surprising link

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

Poison ivy, poison oak and poison sumac rash

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

VEXAS syndrome research reveals overactive bone marrow stem cells may drive inflammation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome—shedding new light on its mechanisms ...

Turning on an immune pathway in tumors could lead to their destruction

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Antibody therapy foils pancreatic cancer's sugar-based disguise to reawaken immune system

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

Immunotherapy resistance in kidney cancer driven by myeloid cell signaling

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.

Todays Updates

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

How access to specialized cancer centers affects glioblastoma outcomes

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...

Todays Updates

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

How access to specialized cancer centers affects glioblastoma outcomes

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...

Latest News

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome—shedding new light on its mechanisms ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.

News All Time

Injectable drug helps asthma patients clear mucus-clogged airways

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says.

FDA approves Tezspire for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ...

Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting pre-made antibodies into patients, this approach encouraged the body to produce its own antibodies to ...

Custom-designed protein receptors help T cells target solid tumors more effectively

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), have revolutionized cancer ...

AI models help pinpoint key neoantigens for personalized skin cancer vaccines

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates ...

In-surgery radiation cuts pancreatic cancer return

Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce ...

Potential cancer outcome differences among psoriasis biologics found

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern suggesting" a lower five-year risk of any first cancer (excluding non-melanoma skin cancer) with ...

Influenza A-infected volunteers display different patterns of expelling viruses into environment

Late in the Middle Ages, Italian stargazers gave a name to the annual contagion that rolled around each year like clockwork. It was a name that stuck, and to this day is known as influenza.

BiTE-based immunotherapy strategy could point the way to a breakthrough for ovarian cancer patients

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and an immune checkpoint ...

Improving immunotherapy responses to fight cancer with dual therapies

Promising study in dual inhibition of PD1 and macrophage migration inhibitory factor

Breastfeeding linked to lasting immune protection against breast cancer

A team of researchers led by Peter Mac's Professor Sherene Loi has uncovered how having children and breastfeeding reduces a woman's long-term risk of breast cancer.

Localized IL-12 delivery reshapes CAR-T safety in solid tumors

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...

Promising new drug combination for melanoma patients resistant to treatment

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard immunotherapy, treatment options are painfully limited. Vanderbilt researchers led by Professor Emerita ...

Mitochondria and lysosomes reprogram immune cells that dampen inflammation

Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system. St. Jude Children's Research Hospital scientists recently uncovered how mitochondria, ...

Decades-old asthma theory challenged: Newly discovered molecules may be real drivers of disease

For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.

Potential antibody therapy restricts the growth of aggressive and treatment-resistant breast cancers

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.

Recommended News For You

New analysis helps discern benign from malignant thyroid growths

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

Colon cancer and exercise: Can physical activity reprogram genes?

Prostate cancer early detection system eliminates need for biopsy.

What is Mohs micrographic surgery? 8 FAQs about Mohs

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

Recommended Articles For You

The Benefits of Understanding Haptoglobin High: What You Need to Know 

What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells 

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells 

Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

2.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

3.

Screening tests that are non-invasive show promise in detecting colorectal cancer.

4.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

5.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

1.

Unmasking the Hidden Symptoms of Ovarian Cancer

2.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

3.

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms 

4.

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025

5.

Gene Therapy for Hemophilia: A New Hope on the Horizon

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

4.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot